Metraipolis › archive › dc_fdb96de3acc0

Complement-targeted therapies for C3 glomerulopathy and atypical hemolytic uremic syndrome: a time-limited rapid systematic review with narrative synthesis — Europe PMC PMID:42621905

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42621905
DOI
10.3389/fmed.2026.1867718
License (as archived)
solo-consultazione
Archived
2026-10-08T07:56:07.944Z
SHA-256 of the archived text
58b454c52687a5cbc0717fcd641efb583585e9a9d1e78aa2bd563ba12249ba33
Stable URL of this page
https://metraipolis.com/documento/dc_fdb96de3acc0

How to cite

Complement-targeted therapies for C3 glomerulopathy and atypical hemolytic uremic syndrome: a time-limited rapid systematic review with narrative synthesis — Europe PMC PMID:42621905 — Europe PMC (en), https://europepmc.org/article/MED/42621905 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fdb96de3acc0 (Metraipolis archive dc_fdb96de3acc0, sha256 58b454c52687a5cbc0717fcd641efb583585e9a9d1e78aa2bd563ba12249ba33)
BibTeX
@misc{dcfdb96de3acc0,
  title = {Complement-targeted therapies for C3 glomerulopathy and atypical hemolytic uremic syndrome: a time-limited rapid systematic review with narrative synthesis — Europe PMC PMID:42621905},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42621905},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fdb96de3acc0; sha256 58b454c52687a5cbc0717fcd641efb583585e9a9d1e78aa2bd563ba12249ba33},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42621905. Agents can read the archived copy with the MCP tool read_document.